Indian biotech sector is witnessing a quantum surge in terms of growth of the industry. The growth can be attributed to a large pool of scientific talent, world-class information technology industry, and vibrant biopharmaceutical sector. Government initiatives, like setting up of more biotech parks and encouragement to public-private-partnerships, provided extra cushion to the biotech industry against tough economic conditions of recession.
According to our new research report, “Booming Biotech Market in India”, during FY 2009- 2011, the market witnessed an impressive CAGR of around 19.2% and generated total revenue of INR 172.5 Billion in FY 2011. The biotech market is further expected to accelerate in near future and is expected to reach INR 341.2 Billion by FY 2014 on the back of high demand for vaccines, CROs, biopesticides, biofertilizers, and biodiesel in India as well as at the global level.
Our research has found that the bioagriculture segment is the fastest growing segment of the biotech sector. It has experienced a double digit growth over the last two years and the trend is likely to continue in future as well. The baseline for optimistic future projection of this segment is the success of BT products in India and a large number of vegetable crops in the pipeline to be commercialized. Moreover, investments are also pouring to promote research and developing capability to produce biofuel to reduce its dependence on oil and improve energy security.
Our report further provides comprehensive information, rational analysis and reliable statistics of the biotech market in India. The report has thoroughly examined current market trends government initiatives industrial developments and funding and competitive landscape to enable clients understand the market structure and its progress in coming years.
According to our new research report, “Booming Biotech Market in India”, during FY 2009- 2011, the market witnessed an impressive CAGR of around 19.2% and generated total revenue of INR 172.5 Billion in FY 2011. The biotech market is further expected to accelerate in near future and is expected to reach INR 341.2 Billion by FY 2014 on the back of high demand for vaccines, CROs, biopesticides, biofertilizers, and biodiesel in India as well as at the global level.
Our research has found that the bioagriculture segment is the fastest growing segment of the biotech sector. It has experienced a double digit growth over the last two years and the trend is likely to continue in future as well. The baseline for optimistic future projection of this segment is the success of BT products in India and a large number of vegetable crops in the pipeline to be commercialized. Moreover, investments are also pouring to promote research and developing capability to produce biofuel to reduce its dependence on oil and improve energy security.
Our report further provides comprehensive information, rational analysis and reliable statistics of the biotech market in India. The report has thoroughly examined current market trends government initiatives industrial developments and funding and competitive landscape to enable clients understand the market structure and its progress in coming years.
- 1. Analyst View
- 2. Indian Biotechnology Industry
- 2.1 Market Overview
- 2.2 Market Segments
- 2.2.1 Biopharmaceuticals
- 2.2.2 Bioservices
- 2.2.3 Bioagriculture
- 2.2.4 Industrial Biotechnology
- 2.2.5 Bioinformatics
- 2.3 Biosupplier Industry
- 3. Biotech Funding and Investments
- 3.1 Major Investments
- 3.2 Tie Ups
- 4. Indian Bioclusters
- 4.1 Southern Region
- 4.1.1 Andhra Pradesh
- 4.1.2 Karnataka
- 4.1.3 Tamil Nadu
- 4.1.4 Kerala
- 4.2 Western Region
- 4.2.1 Maharashtra
- 4.2.2 Gujarat
- 4.3 Northern Region
- 4.3.1 Uttar Pradesh
- 4.3.2 Punjab
- 4.4 Eastern Region
- 4.4.1 West Bengal
- 5. Government Initiatives
- 6. Emerging Sectors
- 6.1 BIosimilars
- 6.2 Stem Cell Research
- 6.3 Nanobiotechnology
- 6.4 Monoclonal Antibody
- 6.5 Oncology
- 7. Key Players Analysis
- 7.1 Biocon
- 7.2 Serum Institute of India
- 7.3 Panacea Biotec
- 7.4 Nuziveedu Seeds Limited
- 7.5 Reliance Life Sciences
- List of Figures:
- Figure 2-1: Biotechnology Market (Billion INR), FY 2010 to FY 2014
- Figure 2-2: Biotechnology Market by Segment (%), FY 2011
- Figure 2-3: Biotechnology Market by Exports & Domestic Consumption (%), FY 2011
- Figure 2-4: Biopharmaceuticals Market (Billion INR), FY 2010 to FY 2014
- Figure 2-5: Biopharmaceuticals Market by Exports & Domestic Consumption (%), FY 2011
- Figure 2-6: Biopharmaceuticals Market by Segment (%), FY 2011
- Figure 2-7: Vaccine Market (Billion INR), FY 2010 to FY 2014
- Figure 2-8: Therapeutics Market (Billion INR), FY 2010 to FY 2014
- Figure 2-9: Therapeutics Market by Segment (%), 2010
- Figure 2-10: Diagnostics Market (Billion INR), FY 2010 to FY 2014
- Figure 2-11: Bioservices Market (Billion INR), FY 2010 to FY 2014
- Figure 2-12: Bioservices Market by Exports & Domestic Consumption (%), FY 2011
- Figure 2-13: Number of Clinical Trials (2007 & 2009)
- Figure 2-14: Clinical Trials by Phase (%)
- Figure 2-15: Clinical Trials by Therapy (%)
- Figure 2-16: Clinical Research Outsourcing Market (Million US$), 2009-2015
- Figure 2-17: Share of Top Companies in Bioservices Market (FY 2011)
- Figure 2-18: Bioagriculture Market (Billion INR), FY 2010 to FY 2014
- Figure 2-19: Bioagriculture Market by Exports & Domestic Consumption (%), FY 2011
- Figure 2-20: Share of Top Companies in Bioagriculture Market (FY 2011)
- Figure 2-21: Industrial Biotechnology Market (Billion INR), FY 2010 to FY 2014
- Figure 2-22: Industrial Biotechnology Market by Exports & Domestic Consumption (%), FY 2011
- Figure 2-23: Share of Top Companies in Industrial Biotechnology Market (FY 2011)
- Figure 2-24: Bioinformatics Market (Billion INR), FY 2010 to FY 2014
- Figure 2-25: Bioinformatics Market by Exports & Domestic Consumption (%), FY 2011
- Figure 2-26: Share of Top Companies in Bioinformatics Market (FY 2011)
- Figure 2-27: Biosupplier Industry (Billion INR), FY 2010 to FY 2014
- Figure 2-28: HPCL Market Distribution (%), FY 2011
- Figure 4-1: Biotechnology Market by Region (%), FY 2011
- Figure 4-2: Biotechnology Market by State (%), FY 2010
- Figure 4-3: Biotechnology Market by City (FY 2010)
- Figure 7-1: Share of Top Companies in Biotechnology Market (FY 2011)
- List of Tables:
- Table 2-1: Growth Infectious Diseases Diagnostic Market (2004-2008)
- Table 2-2: Growth in Hormones Diagnostic Market (2004-2008)
- Table 2-3: Growth in Blood Grouping Reagents Diagnostic Market (2004-2008)
- Table 2-4: Growth in Pregnancy Diagnostic Market (2004-2008)
- Table 2-5: Growth in Cancer Markers Diagnostic Market (2004-2008)
- Table 2-6: Top Five Biopharmaceutical Companies by Revenue (Billion INR), FY 2011
- Table 2-7: Breakup of Estimated Area under Cultivation and Production of BT Cotton by State
- Table 2-8: Top Ten Biosupplier Companies by Revenue (Billion INR), FY 2011
- Table 4-1: Leading Biotechnology Companies in Southern Region by Revenue (Billion INR), FY 2011
- Table 4-2: Leading Biotechnology Companies in Western Region by Revenue (Billion INR), FY 2011
- Table 4-3: Leading Biotechnology Companies in Northern Region by Revenue (Billion INR), FY 2011
- Table 6-1: Patents Expiries (Billion US$)
- Table 7-1: Top Ten Biotechnology Companies by Revenue (Billion INR), FY 2011
Other selected research from the 'Markets' category:
India: Pharmaceutical and biotechnology opportunities
The report provides an overview of the Indian pharma and biotech market, and answers the following key questions:
- Who are the key players in the Indian pharmaceutical market?
- How has the Indian regulatory environment changed?
- What R&D collaborative opportunities are available?
- How can companies engage with India for collaboration?
- What are the leading R&D companies in India doing in collaborative R&D?
Indian Biotech Industry (2005)
The market research report also details the success of the biotech firms in terms of their business profiles, export outlets, financial performances and future plans Learn More
Other selected research from the 'India' category:
Booming Hospital Services Market in India
The hospital services market represents one of the most lucrative segments of the Indian healthcare industry. Various factors such as, increasing prevalence of diseases, improving affordability, and rising penetration of... Learn More
Booming Pharma Sector in India
This dramatic growth in the Indian pharmaceutical industry can be attributed to several factors such as growing middle class population, rapid urbanization, increase in lifestyle-related diseases and acceptance of health insurance. Learn More